Eurofins Viracor: All Resources

Watch the on-demand webinar where we’ll examine the diagnostic challenges of endemic mycoses, including histoplasmosis and coccidioidomycosis. Learn how emerging tools are helping overcome limitations in identifying dimorphic fungi and improving outcomes in invasive fungal infections. The session features expert insights and a live Q&A. Don’t miss this opportunity to advance your understanding of fungal diagnostics.

Now available on-demand: A case-based webinar on non-tuberculous mycobacterial (NTM) PCR testing, exploring its clinical implications and practical applications. Discover how rapid PCR testing has advanced the detection and management of NTM infections. Dr. Mirza Haider Ali shares real-world insights into how timely, accurate diagnostics can support earlier intervention and improve patient outcomes.

Eurofins Viracor’s white paper details the analytical validation of a hybrid capture sequencing assay for detecting invasive fungal and bacterial infections (IFBIs) from plasma and BAL samples. The assay demonstrated high sensitivity and specificity, with strong concordance to qPCR results and reduced polymicrobial reporting. This targeted approach enhances diagnostic accuracy and interpretability, especially for immunocompromised patients.

View our Webinar "TTV Torque Teno Virus Immunologic Monitoring" to learn more about how TTV monitoring can enhance transplant patient management and improve clinical outcomes.

View our Webinar "Fungal Infections in Transplant Recipients: A Case-Based Approach" to learn more about how TTV monitoring can enhance transplant patient management and improve clinical outcomes.

Download our TTV Risk Stratification Guide to learn more about how TTV monitoring can enhance transplant patient management and improve clinical outcomes.

Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Consensus Definitions & Up-to-Date Management

In this post, we emphasize the critical need for nontuberculous mycobacteria (NTM) and fungal testing for patients undergoing CAR T-cell therapy. While this innovative treatment has shown effectiveness against certain cancers, it significantly suppresses the immune system, making patients more vulnerable to opportunistic infections...

Watch the on-demand webinar where we’ll explore the significance of TTV in clinical settings and its potential as an objective aid for modifying immunosuppression in transplant recipients. Discover the latest diagnostic tools and methodologies that utilize TTV, along with real-world examples showcasing its impact on patient outcomes. The session will also include an interactive Q&A. Don’t miss this opportunity to enhance your understanding of TTV in transplant care!

Explore our NTM abstract poster on "Development and Validation of a Suite of Multiplexed PCR Assays for the Detection and Differentiation of Non-Tuberculous Mycobacteria."